# GLP-1 Hair Loss: What the Research Says and What to Track
Source: https://www.trackpep.com/blog/glp-1-hair-loss-what-to-track
> Educational information only. Not medical advice, and not a dosing recommendation. TrackPep records what you enter; it never calculates, converts or decides a dose for you. Talk to a licensed clinician.
A 2026 Penn Medicine study in The BMJ linked GLP-1 drugs to more hair-loss diagnoses. Here is what it found, why shedding happens, and what to log for your clinician.
## Short answer
A 2026 Penn Medicine study in The BMJ found people with type 2 diabetes who started a GLP-1 drug were diagnosed with hair loss somewhat more often than those on other diabetes drugs, mostly non-scarring and often reversible. It shows association, not proof of cause. Track shedding, photos and weight trend, and tell your clinician.
## The short version
Hair thinning on a GLP-1 drug is now backed by a large dataset, but the dataset shows an association, not a verdict. A 2026 study from Penn Medicine, published in The BMJ, compared hair-loss diagnoses in adults with type 2 diabetes who started a GLP-1 drug against adults who started other diabetes drugs. The GLP-1 group was diagnosed with alopecia more often. The excess was small in absolute terms, concentrated in non-scarring (usually reversible) types, and the authors think rapid weight loss is the most likely driver.
This article covers what the study reported, why shedding happens at a high level, what is worth writing down, and when to stop tracking and ask a professional. It is general information, not medical advice.
**Where these numbers come from.** We checked the figures against several news and medical-press reports of the paper (linked under Sources). We did not have the full BMJ text open, so treat specific numbers as secondhand and read the paper itself, or ask your clinician, before relying on them.
## What the Penn Medicine study found
According to the reports we checked, the researchers used electronic health records from the Penn Medicine system covering January 2019 to September 2024. They compared adults with type 2 diabetes who newly started a GLP-1 receptor agonist (semaglutide and tirzepatide were among the drugs) with people who newly started an SGLT-2 inhibitor or a DPP-4 inhibitor. Each comparison involved roughly 11,000 to 15,000 people per group, around 24,000 or more in each pairing.
| Point | What was reported |
|---|---|
| Design | Observational cohort using health records, target trial emulation |
| Who | Adults with type 2 diabetes starting a new drug |
| Comparators | SGLT-2 inhibitors and DPP-4 inhibitors |
| Main result | Higher rate of new alopecia diagnoses with GLP-1 drugs |
| Size of effect | Hazard ratio about 1.37 versus SGLT-2 and about 1.68 versus DPP-4 |
| Subtype | Signal was in non-scarring alopecia, the usually reversible kind |
| Absolute risk | Roughly 4 to 7 diagnoses per 1,000 person-years; GLP-1 groups a couple of cases per 1,000 higher |
| Likely mechanism (authors) | Weight loss and reduced calorie intake |
Two cautions the authors and commentators raised are worth keeping in mind:
- **Association, not causation.** An observational study cannot separate the drug from the weight loss, the diet change, or other differences between groups. Reports also say the associations weakened after a statistical calibration using negative control outcomes.
- **Limits of the data.** The authors could not assess severity, how much hair was lost, how long it lasted, or whether it recovered after stopping the drug. A diagnosis in a record is not the same as everyone who notices extra shedding in the shower.
It also studied people with diabetes. Coverage notes it does not establish the size of risk for people using GLP-1 drugs for weight management alone. Reports also say the FDA is looking at this as a possible safety signal, which is a reason to talk to your prescriber, not a reason to stop a medicine on your own.
## Why hair sheds after fast weight loss
The best-established explanation for diffuse shedding after weight loss is not specific to GLP-1 drugs. It is called **telogen effluvium**.
Hair follicles cycle through a growing phase, a short transition, and a resting phase before the hair falls out. Normally only a small share of follicles are resting at any time. A physical or physiological stressor can push a larger share into the resting phase at once. A few months later, those hairs shed together, which is why people often notice it well after the trigger.
Commonly described triggers include:
- Rapid or large weight loss and a sharp drop in calorie intake
- A shortfall in protein, iron, or other nutrients while eating much less
- Illness, fever, surgery, or major emotional stress
- Childbirth, certain medications, and thyroid problems
The key feature for tracking is the **delay**. Shedding commonly appears around two to four months after the trigger and then often settles once the trigger passes, though your own timeline can differ. That means the shower drain in month four may reflect what happened in month one or two, and a dated log is the only reliable way to see that link.
Telogen effluvium is a general mechanism; whether it explains your hair is something only an in-person assessment can say. Other causes, including thyroid disease, iron deficiency, hormonal conditions and patterned hair loss, can look similar.
## What to track
The goal is a record your clinician can use. You are not diagnosing yourself. These are the items worth writing down:
| What | How | Why it helps |
|---|---|---|
| Shedding notes | A quick weekly score (none, mild, heavy) plus where you notice it | Shows whether it is rising, steady or easing |
| Photos | Same spot, same light, hair parted the same way, every 2 to 4 weeks | Memory of thinning is unreliable; photos are not |
| Hair-wash days | Count washes per week | Shedding on wash days rises with fewer washes, so the count gives context |
| Weekly weight trend | The weekly average, not daily numbers | Lets you see whether shedding follows a fast stretch of loss |
| Lab dates and results | Dates and values for tests your clinician orders, such as iron studies, ferritin, vitamin D or thyroid | Gives a timeline; you do not need to order anything yourself |
| Protein and meal notes | Rough intake, or just how well you are eating | Context for a conversation about nutrition |
| Stress, illness, surgery | Date and a one-line note | These are independent triggers and easy to forget |
| Other medications | Start and stop dates | Many medicines list hair changes as a possible effect |
| Your treatment dates | Start date and any change your prescriber makes | Lets a clinician line shedding up with the timeline |
### A simple monthly review
1. Open your photos from the last three months side by side.
2. Look at your weight trend line for the same period.
3. Check the dates of any illness, stress or medication change.
4. Note whether shedding is rising, steady or easing.
5. Bring the summary to your next appointment.
TrackPep can hold this alongside your doses: its [GLP-1 tracker](/glp-1-tracker), [semaglutide tracker](/semaglutide-tracker) and [tirzepatide tracker](/tirzepatide-tracker) pages show how the logging works. It records what you enter and shows your own history. It does not interpret it or suggest changes to treatment.
## Myths versus evidence
| Claim you may see | What the evidence supports |
|---|---|
| "The drug is attacking your hair follicles" | No such mechanism is shown. The authors point to weight loss and reduced intake as most likely. |
| "It is always permanent" | The signal was in non-scarring types, generally reversible, though recovery was not measured here. |
| "Everyone on GLP-1 drugs loses hair" | Absolute risk was low, a few cases per 1,000 person-years. Most people are not diagnosed. |
| "Slower weight loss means no shedding" | Plausible direction, but not proven. No tracking habit guarantees you avoid it. |
| "This only happens with one brand" | The study grouped GLP-1 drugs including semaglutide and tirzepatide; it did not establish one brand as safer. |
| "A supplement will fix it" | Evidence depends on the cause. Whether any supplement is appropriate is a question for your clinician, especially since some can be harmful in excess. |
| "Lab results are all you need" | Labs help look for treatable causes, but a normal result does not rule out telogen effluvium. |
## What a clinician may want to look at
It is useful to know what the visit might cover, so you can bring the right notes. We cannot tell you what you need. A clinician or dermatologist may ask about:
- The timeline of weight loss and diet changes
- Illness, surgery, childbirth or stress in the last six months
- Family history of hair loss
- Medication changes
- Scalp appearance and the pattern of loss (diffuse, patchy, receding)
- Whether to order bloodwork. Our overview of [common bloodwork panels](/blog/peptide-bloodwork-panels-guide) explains the terms, without telling you which tests you need.
If you are eating much less than before, our posts on [how much protein people report on GLP-1 drugs](/blog/how-much-protein-on-glp-1) and [weight tracking trends](/blog/weight-tracking-on-glp-1) cover how to log intake and read your weight line. For other effects worth logging, see the [GLP-1 side-effects tracker](/blog/glp-1-side-effects-tracker).
## When to see a clinician or dermatologist
Shedding is common and often self-limiting, but do not wait if you notice any of these:
- Shedding that is heavy, or lasts beyond roughly six months
- Round or patchy bald spots, or hair breaking rather than falling out at the root
- Scalp pain, burning, redness, scaling or scarring
- Thinning that comes with fatigue, feeling cold, unusual weight change, heavy periods or other new symptoms
- Distress about how you look, which is a perfectly good reason to seek help
Do not stop or change your GLP-1 medicine because of hair changes without speaking to the person who prescribed it. Do not start supplements, topical products or other treatments on the advice of a social media post. What is suitable depends on the cause, and that needs a real examination.
## Keeping it in perspective
The study is useful because it takes a common anecdote and gives it a number. It does not say hair loss is likely for any one person, and it does not show the drug itself is responsible. What it does support is a practical step: if you are losing weight quickly, expect that your body may notice, write down what changes, and make the conversation with your clinician specific instead of vague.
A calm, dated log turns "my hair feels thinner" into "shedding rose in month three, after eight weeks of fast loss and a bad flu, and my last labs were in June." That is something a clinician can work with.
## Frequently asked questions
### Do GLP-1 drugs cause hair loss?
The 2026 Penn Medicine study in The BMJ found an association, not proof of cause. Adults with type 2 diabetes who started a GLP-1 drug were diagnosed with hair loss more often than those who started SGLT-2 or DPP-4 inhibitors. The authors point to rapid weight loss and reduced calorie intake as the most likely explanation.
### Is GLP-1 hair loss permanent?
The signal in the study was concentrated in non-scarring alopecia, the type that is generally reversible. The authors could not measure how long it lasted or whether it recovered after stopping treatment, so nobody can promise a timeline. Ask a clinician about your own case.
### How common is it?
Absolute numbers were low. Secondary coverage of the paper reports roughly 4 to 7 new diagnoses per 1,000 person-years across the groups, with the GLP-1 group a couple of cases per 1,000 per year higher than comparators. These are diagnoses recorded in health records, not everyone who notices extra shedding.
### What should I log if my hair is thinning?
Dated photos in the same light, a rough shedding note, hair-wash days, your weekly weight trend, the dates of any labs your clinician orders, illness or stress events, and any new medications. A dated record lets your clinician see whether shedding lines up with fast weight loss.
### When should I see a clinician about hair loss?
Book a visit if shedding is heavy, lasts beyond a few months, comes with patchy bald spots, scalp pain, redness or scarring, or arrives alongside fatigue or other new symptoms. Do not start supplements or treatments on your own without talking to a clinician.
## Sources
- [GLP-1 receptor agonists may increase hair loss risk (News-Medical, 22 July 2026, report on the Penn Medicine BMJ cohort study)](https://www.news-medical.net/news/20260722/GLP-1-receptor-agonists-may-increase-hair-loss-risk.aspx)
- [GLP-1 receptor agonists tied to increased risk for alopecia (HealthDay)](https://www.healthday.com/healthpro-news/skin-health/glp-1-receptor-agonists-tied-to-increased-risk-for-alopecia)
- [GLP-1 drugs linked to temporary hair loss, here is why (Medical News Today)](https://www.medicalnewstoday.com/articles/glp-1-drugs-linked-to-temporary-hair-loss-heres-why)
- [Telogen Effluvium (StatPearls, NCBI Bookshelf)](https://www.ncbi.nlm.nih.gov/books/NBK430848/)
By TrackPep Team.